SPINAL ALIGNMENT INNOVATION REVEALS NEW BENEFITS

SONIK Treatment Solution for Post-Neurosurgery Imbalance
By: Russ Allen, correspondent for HealthTech Reporter

Around the end of 2019, my wife, Kaye was diagnosed with a non-cancerous tumor of the brain, the size of a golf ball. It was determined that surgery was needed. The tumor was sitting right on top of her Pineal gland and resulted in a number of different symptoms. A neurovascular surgeon from New York (Dr. Ng Lin) conducted an MRI guided surgery and was able to successfully excise the tumor without any apparent damage to the brain. 

After that, she had a number of issues with balance and her gait, suspected to be a rare, poorly understood disorder called MAL DE DEBARQUEMENT (MDD) – an issue in the vestibular system that results in a phantom perception of self- motion typically described as rocking, bobbing or swaying. The symptoms tend to be exacerbated when a patient is not moving, for example, when sleeping or standing still- appearing like motion sickness. (1)The inventor of the MRI, Dr. Robert Damadian conducted a post-surgery Fonar MRI while she was sitting up (upper left image) and was able to monitor the brain. He detected a certain amount of seepage of cerebral fluid into the lower left posterior portion of the brain, which he surmised caused Kaye’s MDD symptoms. 

Kaye and I sought a non-surgical solution to this disorder.  We identified the work of Dr. Aslam Khan, the inventor of the SONIK treatment solution as our best option. In discussions with Dr Khan, we learned of the benefits of Dr. Khan’s medical solutions technology utilizing the SONIK medical device which uses sound waves to mitigate the many issues from spine injuries.  A precursor to the SONIK device has been in the clinical market for over 20 years and continues to support the orthopedic community with compelling results(3). It targets the core issues of spinal-related conditions that often lead to painful structural, muscular, and neurological challenges.

In Kaye’s case, she was treated with the device (emitting the pulsed impulses through the device stylus) which is a scientifically validated, non-invasive treatment methodology(2).

We were hoping for an improvement in her gait and balance, which was achieved. An additional unexpected benefit also emerged. The condition observed from the pre-treatment FONAR MRI by Dr Damadian, which displayed  the seepage of cerebral fluid did not appear in the MRI scan by Dr Lin that was done post SONIK treatment. 

Through to date, my wife feels great. Her imbalance symptoms have been resolved. She functions normally; she hikes, she rides bikes daily and goes up and down stairs regularly.  She remains careful with stairs.

Our experience and assessment of the SONIK treatment and Dr. Khan’s concepts of SONIK medicine remains a remarkable find.  Our confidence in Dr. Khan also continues to grow as clinics are expanding throughout the globe- from Canada, the US, Saudi Arabia, Germany, Taiwan, Qatar and more.  As a supporter of breakthrough alternative and functional innovations, this technology continues to inspire exploration.  Having the privilege of experiencing this innovation, my wife and I both fully embrace and endorse the expanded research on the use of this impressive science which Dr. Khan’s clinical leadership had pioneered.

Dr Damadian Pretreatment MRI Scan

Dr Lin Post MRI Scan

EPILOGUE

8/13/2024- Dr. Aslam Khan and Dr. Robert Bard meet for the first time in person to explore collaborative partnerships in support of breakthrough therapeutic technologies.  Dr. Bard, the founder and patriarch of clinical imaging validation through advanced (quantitative) 3D Ultrasound imaging and key principal researcher for IHRC (Integrative Health Research Center, NYC) has expressed major interest in supporting  the expansion of Dr. Khan’s Sonik solution and the vast potential applications of the SONIK technology.  Dr. Bard helped pioneer the use of ultrasound technology in the paradigm of image guided therapies for cancer care and tumor management.  His commitment to advance the expansion of point-of-care ultrasound globally and his support of the non-invasive (non-surgical) movement in medicine aligns with Dr. Khan’s philosophies for treatment and pain care.  “To explore where science and medicine has yet to boldly go where no one has gone before- like the TRICORDER, (a Star Trek Reference) its  where we need to be.  Cutting into the body would someday be a thing of the past… and the impact of energy medicine like this is truly the future that we are finally driving right now”, says Dr. Bard.

References:

1) National Organization for Rare Disorders [Mal de Debarquement]: https://rarediseases.org/rare-diseases/mal-de-debarquement/

2) KKT is a neurospinal innovation/ https://sonik.health/sonik-treatment.php

3) Innovation factory: https://innovationfactory.ca/clients/neuro-spinal-innovation/

TechReview: Exploring the DermaSensor™

Until recently, the approach of identifying skin cancers was commonly a visual self-exam or a clinical exam conducted by a health care provider and/or a dermatologist.  A skin biopsy is the only way to definitively diagnose skin cancer- where a small sample of the suspicious skin is removed and sent to a lab for examination (under a microscope) in search of cancer cells.

HEALTHTECH REPORTER is proud to introduce another non-invasive advancement in skin cancer diagnostics. DermaSensor™ is an AI powered, FDA-cleared innovation designed to help physicians detect skin cancer at the point of care. According to a recent DEMO DAY @ Bard Diagnostics in NYC, clinical educators provided a comprehensive tour of what appears to be a ground-breaking innovation for primary care physicians "offering actionable results to aid in skin cancer detection by assessing cellular and sub-cellular features that cannot be seen visually or dermoscopically". 

DermaSensor™ was designed as a portable and fast-access noninvasive point-of-care assessment tool for primary care physicians to offer additional information about a lesion to aid in their consideration of a referral decision. (DermaSensor™ does not definitively determine whether or not cancer is present, specify what type of cancer may be present, or make any decision for the user.)

By examining the difference in light scattering, DermaSensor™ determines if the skin lesion suggests to “Investigate Further” or “Monitor” - as an immediate output. Elastic Scattering Spectroscopy (ESS) has been validated in 30+ publications on clinical studies. Many studies have shown ESS to provide information that is comparable to histopathologic assessment in the analysis of cellular microscopic structure.*

 

(Image 1-Right) The solid red line is malignant melanocytic lesions. The solid blue line is benign melanocytic lesions and the dotted lines are for malignant non-melanocytic and benign non-melanocytic lesions. And the separation here is the varying spectral signatures for these different categories, and it uses dozens of these wavelengths to discern malignant from benign tissue. for example, it does not use ~600 microns in the center where the lines overlap. That's the reflectance of hemoglobin.

According to Dr. Kiran Chatha (medical science liaison), DermaSensor™ uses the science of Elastic Scattering  Spectroscopy layered with a machine learning algorithm. ESS shines visual light from approximately 350 to 850 nanometers of light onto a given lesion. Based on the reflectance of the intensity of the photons of light, it's able to create a chart which is then compared to spectral signatures which are validated for different tissue types. DermaSensor’s™ tip reflects and records pulses of light off the lesion’s cellular and sub-cellular content. The built-in computer analyzes the light to provide information to help physicians assess skin lesions (including melanomas, squamous cell carcinomas, and basal cell carcinomas) to aid in a referral decision.

DEMO DAY: 

DERMASENSOR PERFORMANCE TEST By Dr. Robert L. Bard

When our scheduler locked down an official device demo of the DermaSensor™, my skin imaging team and I were excited to explore the future of skin cancer detection and how AI truly plays a role in intelligent scanning.  This is the first that we have experienced that inspired the level of confidence to provide immediate objective cancer risk information to PCPs. We originally learned about this technology from Dr. Alina Bridges, Dermatopathologist @ Northwell Health and research collaborator for the DermaSensor™ team. She presented her involvement in an upcoming (FDNY) firefighter skin cancer screening promoted by the American Academy of Dermatology. She also mentioned the technology was being considered for the program. Though the AAD did not learn of this technology in time to evaluate it for this program, she piqued our interest in this device and the science of Elastic Scattering Spectroscopy (EES) as one that may raise the bar for skin cancer detection. 

We stacked the day with patients with chronic skin disorders from basal cell carcinoma, squamous cell carcinoma, and melanoma.  We also brought in patients who recently underwent mohs surgeries to remove malignant lesions.  One by one, the device was surprisingly 'spot on' with its challenge to determine the skin pathologies of each volunteer. We found this performance test to fully quantify each lesion.

My research group conducted their own homework on the technology and found their R&D efforts to rank highly in accuracy and efficacy. With their reported sensitivity rating of 96% and a negative predictive value of 97%, the science of a non-invasive, portable, AI-powered data scanning aligns with our entire med-tech movement trends. 

As a skin cancer radiologist, I have always been passionate about validating pathologies based on a comparative (side by side) view from above the skin and underneath. I relied on the latest quantitative imaging solutions (3D Doppler Ultrasound, Reflectance Confocal Microscopy etc). This DermaSensor™ satisfies both the current status of the malignancy, but its database guides the physician as far as what the malignancy could mean and recommends next steps.

Beneath this simple-looking device holds a vast amount of data to identify a skin anomaly and its malignancy.  I'm told that it is a common question to ask whether this competes with dermatologists, but I immediately see how this actually elevates the reliance between the PCP and the skin specialist. My colleagues in the dermatology society would certainly welcome the benefits that it provides in 1) resulting in more skin cancers detected and referred from primary care, and 2) the objective risk output helps PCPs prioritize referral of high-risk lesions with a PPV of 40% for 8-10 scores (i.e. a NNR of 2.5).

Overall, we found the technology to be quite intelligent and expect the patient care market to embrace this device. It is priced well and is backed by a significant amount of proven research. Their team of dermatology and primary care medical advisors and research collaborators are certainly well recognized in the industry, winning significant votes of confidence within the medical community.

DERMASENSOR MAKES MEDICAL NEWS

The first medical news headline about DermaSensor™  began in May of 2021 where the developers of DermaSensor™  were awarded Breakthrough Device Designation by the FDA-  acknowledging that the DermaSensor™ device is a supportive tool to primary care providers by addressing life-threatening disease and is expected to offer improved effectiveness compared to currently available products. “DermaSensor’s ability to analyze cellular-level features, which is invisible to the human eye even when aided by a dermatoscope, and to accomplish this in seconds, is already empowering clinicians at the important moment of patient assessment and medical decision making", said Cody Simmons, co-founder and Chief Executive Officer of DermaSensor. 

In January 2024, DermaSensor™ received official FDA clearance of its First-In-Class Device and is shaping the future of its market by winning deserved recognition and innovation awards for its continued advancement in cancer diagnostics. An article in Nature agrees, as it describes the FDA’s authorization of this device as “a pivotal moment in digital health innovation” and “establishes a new regulatory precedent for FDA authorization of medical devices incorporating AI and ML technologies within dermatology.”

SPECIAL THANKS:  We wish to express our deep appreciation for the generosity of Mr. Cody Simmons (CEO), Dr. Kiran Chatha, Ms. Ruth Stachura and Dr. Alina Bridges- with whose kind efforts this report could not have been made possible. Healthtech Reporter and Dr. Bard are in no way compensated nor otherwise conflicted with DermaSensor, Inc.

THE CRITICAL ROLE OF DIAGNOSTICS IN HEALTH AND WELLNESS  By: Dr. Jess Sabrowsky DNP, RN, FNP-BC What I have learned over the years is the importance of listening to the patient, but equally, the importance of using data-driven diagnostics to make real-time decisions about care. This is not just about numbers on a chart—it is about understanding the full picture of your health, long before symptoms arise. We need to use technology, diagnostics, and assessment techniques to gather real data. Data that can guide each patient on their unique health journey. Diagnostics help us understand the true state of a person’s health, even when they may not feel “sick.” This is where the rubber meets the road: when you find a PCP who truly understands the importance of these tools and works with you to achieve your wellness goals and who also has skills beyond the transitional medical model to help you live your best life. Having difficult conversations is uncomfortable, but it is necessary for growth. If you want a healthcare provider who will partner with you—someone who creates a safe space, builds trust, and encourages honest dialogue to support long-term growth—then you must also be willing to put in the effort. Finding a provider who matches your commitment to your health, and one who uses diagnostics to empower you, is key to achieving your goals. WHY DIAGNOSTICS MATTER In short, diagnostics are essential because they offer concrete, actionable insights into your health that go beyond surface-level symptoms. They help uncover hidden health risks and enable early intervention, which can be the difference between preventing a chronic condition or managing it effectively. Diagnostics allow for personalized care tailoring interventions to meet the specific needs of the individual based on real, measurable data. I also would add that as a provider I prefer to reference functional lab ranges when reviewing results as I find that I can make small preventative recommendations and also challenge individuals and providers to think outside the box when looking to help resolve health conditions, like in the case of my daughter who otherwise would still be suffering. Let’s aim to stop the suffering and optimize wellness for all who seek it.

Copyright Notice: The materials provided on this website/web-based article are copyrighted and the intellectual property of the publishers/producers (HealthTechReporter.com, Alliance/IntermediaWorx inc. and The AngioFoundation). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

KHAN

 this device kind of falls between, um, so from a realignment perspective, you know, we, we do what we do, uh, and very, very, very, you know, very objectively, and it's also, uh, very visually appealing. Um, and it re it removes the need for, you know, cracking and pulling people's back and, and snapping them and giving them TIAs. Um, so, so that's one side of it, uh, does it consistently without any, you know, with, without any deliberation whatsoever. Um, and as precisely as it's humanly possible. So that's one side of it. On the other side, from a regenerative standpoint, it almost, you know, people who would normally be using PRP and, and, and trying to, you know, uh, experiment with stem cells and all of that, this kind of knocks it out out of the park. So we get tremendous immediate outcomes where there is to the knee, to the shoulder, to soft tissue, and, and most importantly, to cartilage and ligaments. Where that, where that sort of Absolutely. 

So, so where we are with the technology is that, is that currently, I mean, our, our most, the most important thing right now is to be able to put this hand, the technology to the hands of, of clinicians, you know, across the country. That's got to happen. I mean, we just cannot delay anymore. It's, it's, uh, you know, it's, it's, it's, it's, it's so delayed in for, you know, in getting to, into the hands of the clinicians to begin with that I feel guilty about it every single day. And, um, and I think, you know, the, the needless pain and suffering of patients is, is what kind of drives me crazy. You know, every time I think about all the people who are, you know, suffering where this technology in a matter of minutes can change their life, um, you know, and they don't have access to it. And now we've got an FDA clearance, we have the whole, everything is wide open for us. And, uh, now it's just a matter of really placing into the hands of, of, well-meaning people. 

 I can take all the credit for it, but, you know, somewhere, somehow things came and happened and I walked into it and, uh, and I think it was, it was truly a game changer for us to be able to use sound in, in treatment, uh, starting many years ago. And, um, and I think what you'll, what you'll find is that, um, in the years to come, this is going to be the cornerstone of how we apply medicine. There is no question. If there's one thing I can leave behind in this conversation, it's that watch out because there is laser use and there's, you know, there's many other uses as well, uh, chemical use of drugs and surgery and, and, uh, and when it comes to the non-invasive sites, some of the injections and everything, and now they've, they've done their part. 

But when it comes to sound, the, the, the, the implication, the opportunity of being able to tailor it to each person's individual, you know, their own profile, their own individual profile, we just don't have anything that even comes close to that with any other technology. And, you know, and so, um, you know, I think it was, I was very fortunate I walked into it by mistake. And, um, and, you know, I, I opened the curtain and I said, what the hell is this? And, and before I knew it, I had engineers, scientists, researchers working on it, and they spent 10 years of, you know, I spent 10 years of my life just going through the, you know, the grind. And, um, and, but at every corner, the beauty was that at every corner, whenever I would, you know, I would make the next, you know, I would open up the next chapter, I would see something amazing that was even bigger than I imagined. 

I think, I think the beauty is that today, um, the technology has arrived, you know, and, um, and, and, and now in terms of the clinicians, I mean, you know, the joy is that, you know, the more brilliant a clinician and the more thoughtful a clinician is, the more they'll enjoy it and the more they'll discover things that nobody else has discovered and it's at their fingertips, they can apply it. And as long as they're able to capture before and after, they'll know what needs to be done. 

this is gonna be the future of medicine in a big way. It's not gonna be exclusively to this obviously, like everything else, but it's gonna be, it's gonna take on a huge part of our life. If you remember how our man on Star Trek would hold up this, this device and, you know, every time Bones would see somebody with, with an injury, he'd put it up against him. And well, you know, everything else came true in, of Star Trek, whether it was a cell phone or whatever else there was out there in those days. Um, I'm talking about, I'm going back to the original Star Trek, by the way. Unfortunately, I'm dating myself. 

THERMOGRAM - a Tech Review by Dr. Leslie Valle-Montoya

Disclaimer: This is an independent user review by the speaker(s) presenting in this feature. The producers of HealthTech Reporter do not guarantee outcomes of any product nor commercially endorse technologies nor the users who report of them.  

WORK IN PROGRESS- DO NOT DISTRIBUTE (INTERNAL USE ONLY)

In today's world of advanced technology and medicine, artificial intelligence is based on mathematical components, data analytics, predictions, forecasting and more.  In medicine, we can use new advances in technology to be able to detect irregularities at an early stage for detection and prevention.  A healthy lifespan is what we all aspire for in longevity and with advances in non-invasive modalities, we begin to embrace the functions of medicine for early analysis of dysfunction and disease. 

Click to enlarge

The human body can be measured and analyzed by many different forms and diagnostics.  We chose to use Regulation Thermometry which is different from standard thermography.  Instead of an infrared camera to detect heat patterns and blood flow in tissues, Alfa Thermodiagnostics introduces thermography which uses a patented medical-grade infrared sensor and measures the body in 2 states.  Like a stress echocardiography, in order to measure the body we need to place light “stress” to analyze the changes and possible irregularities.  This thermography measures over 100 points in the body twice at a control room temperature.

First, what is Regulation Thermometry? 
Regulation Thermometry uses mathematics and infrared sensors which are calibrated for the human body and involves analyzing changes in skin temperatures before and after exposure to a cool air stimulus. The connections between the skin and the channels with internal organs, this method allows for the indirect assessment of organ and tissue systems.  It is achieved by utilizing the spinal reflex arc and the expression of the Autonomic Nervous System where peripheral nerves connect with organ and tissue signals. The test takes 20 minutes and results are immediate for assessment by the physician.

A traditional thermography scan looks at thermal images caused by vascular components and heat patterns and/or anomalies.  And the scan is done once without the component of stressing the system.   Regulation thermography measures the physiological changes from stress to the whole body to analyze signatures patterns of regulation and dysregulation. 

What does it measure? Cerebrovascular disorders, neuromuscular, brain microbiome infections, thyroid disorder, endocrine function, breast health, prostate function, liver function, dental & gum conditions, pulmonary function, lymphatic function, intestinal disorder and inflammatory conditions. 

Side Note:  The biggest feature I see with Regulation thermography is the ability to have a panoramic dental evaluation of all 32 teeth.  Embryological development of our teeth correlates to an organ and related system of our whole body.  In my training of Biological Medicine, I was guided to analyze dental health first before bypassing the mouth and looking at family history and labs.  The mouth is part of our terrain and it needs to be incorporated into our medical wellbeing. Biological dentist are impressed when their patients come with a copy of their thermography report alarming where there could be a potential infection in the making. 

Applications in Preventive Health: Thermography has a wide range of preventative applications. It is particularly effective in monitoring breast health, where early detection of anomalies can significantly improve treatment outcomes. By using thermography, healthcare providers can track changes over time and identify issues before they develop into more serious conditions.  And changes can be measured frequently non-invasively and radiation-free. This makes it a safe option for regular monitoring, without the risks associated with repeated exposure to radiation.

ANECDOTAL COMPARISONS WITH OTHER DIAGNOSTIC OPTIONS:

Preventative measures: An imbalance and dysfunction can lead to disease. We want to pick up dysfunction at an early stage and do true preventative medicine to change the dysfunction. This technology plays a crucial role in preventative health care. It is not necessary to wait until a certain age to use diagnostics tools to look for abnormalities.  By detecting heat patterns and anomalies in the body, it provides valuable insights that can help in early diagnosis and monitoring of various health conditions.

Conclusion: Recently an article by Journal Cell Metabolism collected over 2,800 facial thermal imaging analysis to reveal the hallmarks of aging and metabolic diseases (Yu et al., July 2, 2024).  Alfa thermography offers a valuable tool using a whole body temperature sensor with infrared coupling- measuring the small temperature changes on the skin. Its non-invasive nature and ability to detect early signs of abnormalities make it an excellent option for regular health check-ups and preventative medicine.  We need to see that the points measured in the body can regulate themselves.  Which translates as tissues able to heal themselves.  By incorporating thermography into your health regimen, you can take proactive steps towards maintaining your well-being and catching potential issues early.

 

DR. GIOVANNA FERRAIOLI: DIAGNOSTIC LIVER RESEARCH ON THE INTERNATIONAL FRONT LINES

I am a hepatologist working at The University of Padua, in Northern Italy (near Milan). I'm conducting the research on liver elastography- assessing diffuse liver disease using elastography for almost 20 years. 

We started first with the FibroScan®-  a dedicated device that assesses the stiffness of the liver while using an ultrasound equipment were available. I started doing research in this case; we use the limb biopsy as the reference standard to assess the accuracy of the method.  We found that elastography was a very accurate method for detecting and staging liver fibrosis.  Currently elastography is used as a reliable substitute for liver biopsy in several clinicals, scenarios and guidelines. 

The World Federation (Forza Medicine and Biology) of Societies for ultrasound medicine and Biology have given all the information we needed about how to perform elastography, and how it can be used not only for staging liver fibrosis, but also for evaluating the outcome of patients affected with diffuse liver disease. Just a few months ago, we completed the guidelines and updated to the guidelines for assessing the liver fibrosis with Shearwave elastography with the guidelines of the World Federation of for ultrasound in medicine and biology. Several studies have been published on hundred of studies using Shearwave for diffuse liver disease.  

Cytosis is assessed with another method that is not elastography. There are other algorithms, however, patients with cytosis are the majority of patients with diffuse liver disease.  We want to assess both the stiffness that is directly related to liver fibrosis and quantifying the amount of fat in the liver.

There are specific algorithms for the quantification of liver fat content, and the majority are based on calculating the attenuation coefficient of the ultrasound beam as it traverses the liver tissue. Stiffness is a different property of the liver tissue.  Stiffness assess biomechanical properties of a tissue that is unrelated to the acoustic properties of a tissue. 

So the art ultrasound, we may find B mode image that is pretty good, but, uh, the liver may be stiffer than normal, and this is due mostly to liver fibrosis. Even though there are, uh, confounding factors, we are assessing stiffness, stiffness may increase not only for liver fibrosis, but also for the inflammation, for infiltrative disease, for, uh, congestive art disease, and, uh, for, uh, cancer, for, uh, focal liver lesions. Elastography, uh, doesn't have a, um, uh, principle role, uh, mostly used for diffuse liver disease for focal level lesions.

Speaker 1 (05:03):

And to, um, characterize them, uh, we use the contrast, the contrast ultrasound that is, uh, completely different. Uh, at the beginning there were, uh, some studies performed assessing the stiffness of a focal lesions, uh, however they say large overlap between, uh, bine and, and malignant liver lesion. And for that reason, elastography has not a, a, a key role in, uh, assessing, uh, focal lesions. Instead for, uh, diffuse liver disease, uh, elastography is a substitute of biopsy, absolutely, yes. But it's already, uh, used for breast. And in, uh, 2015, the world of federation for, uh, art, ultrasound, medicine, and biology. I mean, 10 years ago, uh, issued guidelines for the use of elastography in, uh, breast disease for, uh, assessing, uh, the lesion, uh, in the breast. And now, um, I believe that this year, uh, the update to the guidelines for the breast graphy will be available.

Speaker 1 (06:27):

So, uh, besides, um, the liver, the breast is the organ that is most studied with using elastography. It's used, it's not as easy to perform as we do for, uh, the liver because, uh, it needs, uh, expertise. And again, if you want more detailed information, uh, there, say a, a worldwide expert in, uh, breast elastography living in the states and working in the states in Ohio. That is, uh, Dr. Richard Barr. And you may, uh, reach him if you want to have more details on the use of breast tractography. Uh, we have an, uh, ultrasound school in, uh, <inaudible> that is, uh, endorsed by the Italian Society for Art, ultrasound Medicine in biology. And, uh, we have a colleagues that, uh, attend the school, uh, for practice. And, uh, uh, they are medical doctors in Italy. We do not have, uh, sonographers as in other countries in, uh, Europe.

Speaker 1 (07:44):

So they attend the school to learn now to perform elastography. And generally we have, uh, between 30 and 50, uh, colleagues, uh, each year. They, uh, follow the activity of the ultrasound, uh, uh, unit for, uh, several months. And they get a diploma, uh, by the, uh, endorse by the, uh, Italian society, uh, for razza in medicine and biology. Then we also, uh, have an <inaudible> school. Theum is the European Federation for Razza in Medicine and Biology, and this is a more advanced school for, uh, leader <inaudible>. And to learn how to, uh, perform and to practice in the, our, uh, department and for photo quantification. And we accept, uh, colleagues from, uh, all over the world. We are the colleagues from, uh, Brazil, Argentina, and, uh, other countries in, uh, Europe. They, uh, attend, um, short course, um, generally three days course to learn how to perform as ultrasound, uh, in ay.

ULTRACON 2024- TOP TURNOUT FOR ULTRASOUND INDUSTRY CONFERENCE

For Immediate Release:

DR. ROBERT BARD & ULTRACON 2024: NY RADIOLOGIST DELIVERS RESOUNDING LECTURES ON IMAGING OF INFLAMMATORY DISORDERS TO THE INTERNATIONAL ULTRASOUND STAGE

AUSTIN, TX – April 23, 2024 – UltraCon2024, the ultrasound medicine industry conference hosted by the American Institute of Ultrasound in Medicine (AIUM) in Austin, TX, earlier this month, brought together the who's who in ultrasound medicine technology for a 3‐day event. More than a conference, UltraCon is billed as a "pivotal forum for debate, discovery, and dialogue,” and this year’s event certainly delivered. 

A defining characteristic of UltraCon is the convening of the brightest minds from around the globe who are actively shaping the future of ultrasound medicine. Speakers covered a wide array of topics, from feature‐based reports like the latest uses of 3D Doppler and Elastography, to “tips and tricks” to the complexity of organ‐based scan reviews. 

One such luminary is New York City-based cancer radiologist and internationally published ultrasound researcher Dr. Robert Bard. Elected in 2022 to a 6‐year term on the AIUM Therapeutic Ultrasound Community and became an AIUM fellow in 2022, Dr. Bard was honored to join many of the imaging community's top brands, innovators, and key clinical pioneers in Austin. 

Throughout the week in Austin, Dr. Bard delivered several in‐depth educational presentations on a number of topics, such as "Prostate Elastography," "Microvascular Image Guided Treatment of Arthritis," and an exploratory review of Ultrasound Validation of Pulsed Electromagnetic therapies. 

"It was such a great honor to finally attend one of the largest annual congregations of the finest leaders in imaging science,” said Dr. Bard. “It was invigorating to experience many of their educational presentations in reflection of the continued growth of the ultrasound imaging industry.” 

Dr. Bard also presented his latest research and expanded findings on the power of ultrasound technology on the diagnostics of chronic diseases and musculoskeletal disorders, and as a procedural supporter of image-guided treatments.

"Seeing Dr. Bard deliver his life's work on stage was witnessing legacy in action," says Dr. Lennard Goetze, Executive Director of the Angio Institute. "As a pioneer in the forefront of innovation, he cemented his place in history as one of the influencers of ultrasound advancement and a driver of the next generation."

Click to visit our 2024 UltraCon photo showcase

The AIUM is a multidisciplinary organization established in 1952 designed to advance the art and science of ultrasound in medicine research through educational, scientific, literary, and professional activities. According to Therese Cooper, Director of Accreditation at the AIUM, over 100 master class programs were presented by leading speakers, offering some of the most insightful and expansive reports direct from the field. 

"UltraCon surpassed our expectations in fostering a dynamic exchange of knowledge and ideas within the ultrasound community," said Dr. Richard Hoppmann, President of the AIUM. "The success of this year's conference was due to the caliber of speakers, exhibitors, and attendees, and underscores the vibrant spirit of innovation that drives our field. We are immensely proud of the collaborative advancements discussed and the groundbreaking technologies unveiled here, all of which promise to enhance patient care and shape the future of medical ultrasound."

Over 875 professionals attended to share and exchange information about the latest advancements in noninvasive imaging and the continuance of sonographic science advancement. Another dimension to the programming of Ultracon includes non‐CME sessions, such as a professional video lesson by Dr. Roberta Kline. Dr. Kline’s digital lecture was on the Benefits of Gene Expression in Assessing the Efficacy of Bioenergetic Interventions. 

“This non‐imaging oriented topic was such a great complement to the entire program… it held the scientific spirit of integrative collaboration – the very spirit that supports clinical imaging in the diagnostic community,” stated UltraCon attendee Dr. Leslie Valle-Montoya.

Walking through the exhibitors’ hall, attendees directly connected with some of the top brands at the forefront of ultrasound innovations including SIEMENS, GE, MINDRAY, CANON, SAMSUNG, and FUJI to name a few. Each booth showcased their latest models and was primed and ready to introduce their unique approach to advancing the ultrasound movement. 

Dr. Bard continued, “This event was so impressively organized and I was very inspired to connect, network, and collaborate with the other attendees. The AIUM designed an event that truly empowered the expansion of the clinical community and the future of the ultrasound technology... the AIUM did it right!"

About the AIUM: The American Institute of Ultrasound in Medicine is a multidisciplinary medical association of more than 9,000 physicians, sonographers, scientists, students, and other healthcare professionals. Established in the early 1950s, the AIUM is dedicated to empowering and cultivating a global multidisciplinary community engaged in the use of medical ultrasound through raising awareness, education, sharing information, and research.

---

"ULTRACON 2024- A CONVERGENCE OF DISCIPLINES"

-This year's UltraCon was extra special because it literally happened during a solar eclipse.  The convergence of celestial bodies was a perfect metaphor for the convergence of multiple disciplines across medicine and ultrasound. From radiology and sonography to family medicine, pediatrics and internal medicine, there was so much representation from the primary care specialties within the POCUS community blending with the sonography and radiology communities. Ultracon is unique in that it creates a platform to generate new ideas across specialties and the continuum of care. Together, we get to explore how ultrasound as a technology can interface with the healthcare workflow to improve patient care. The multidisciplinary exchange alongside experts showcasing the advancements in ultrasound such as including artificial intelligence, ultra-portability, and software integration helps fast-track the pathways needed to integrate POCUS into clinical practice.  As a POCUS educator & family physician, UltraCon is the ideal ecosystem for idea exchange and innovation because it links educators, academic researchers, and tech innovators to break free from traditional silos and meaningfully align.  

MENA RAMOS, MD

Co-CEO of Global Ultrasound Institute (GUSI)

"A POWERFUL INDUSTRY NETWORK"

UltraCon provided me the opportunity to converse with individuals at every stage of their career. I networked with individuals whom were just entering the ultrasound realm to renowned radiologists. This was very beneficial as an exhibitor, Probo Medical was able to showcase Probo 360; impeccable service, parts, new and refurbished system sales, and probe sales/repair. UltraCon allowed me to gain an understanding of what customers around the world need and providing solutions to each unique situation.  One case in particular warmed my heart, I had the honor to meet a Physician from Cincinnati Children’s Hospital who was searching for a rare pediatric neuro probe to send to a community clinic in Ethiopia. She had plans to meet with the physician from Ethiopia the weekend after the show, time was of the essence. Probo Medical successfully found this probe and it is currently being used to diagnose children across the world.  UltraCon is definitely an event I will attend again, for the connections and stories alone this event is a must. I hope to see everyone in Florida next year! - 

​Keith Gallagher /  Senior Territory Manager , Probo Medical

BARRIE KOLSTEIN: SURVIVING PROSTATE CANCER & CYBERKNIFE

HealthTech Reporter is proud to present our next CAT'S PAJAMAS AWARD WINNER (yes, it's a real award) to Mr. Barrie Kolstein.  The Kolstein family is a highly recognized name in contemporary classical music for their craftsmanship in Violins, Cellos and Bases. Complimentary to his work for Samuel Kolstein & Son, Ltd. and Kolstein Music, Inc. Barrie also became a notable editor and contributor within the world of classical music, publishing numerous technical articles on restoration and appraisals in the International Society of Bassists with a feature article published in The Strad, February 1991. Barrie was also published regularly in the Double Bassist magazine and the Strad magazine, both of London, England, from 1996. These articles have ranged form interviews with makers and performers, technical articles on repair/making, and expert appraisal articles on historic master makers. Barrie also serves as editor of the “Luthier Corner” in the International Society of Bassists magazine restoration and repair forum.

Our editors have had the distinct pleasure of conducting an exclusive interview with Mr. Kolstein about his journey to battle Prostate cancer, his experience-based advocacy about "Getting Checked NOW!" and his earlier experiences with cancer- undergoing his late wife's battle.

Coming soon: THE KOLSTEIN INTERVIEW (HIGHLIGHTS)

Sponsored AD: